Akt1 isoform modulates phenotypic conversion of vascular smooth muscle cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 11, 2014, Pages 2184-2192

  Yun, Sung Ji ^a,b   Ha, Jung Min ^a,b   Kim, Eun Kyoung ^a,b   Kim, Young Whan ^a,b   Jin, Seo Yeon ^a,b   Lee, Dong Hyung ^a   Song, Sang Heon ^a   Kim, Chi Dae ^a,b   Shin, Hwa Kyoung ^a   Bae, Sun Sik ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Akt; Integrin linked kinase; Laminin; Neointima; Phenotypic change

Indexed keywords

AKT 1 PROTEIN; ANGIOTENSIN II; COLLAGEN GEL; INTEGRIN LINKED KINASE; LAMININ; MYOCARDIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY LIGATION; CELL CULTURE; CELL PROLIFERATION; LIPID DIET; MALE; MUSCLE CONTRACTILITY; NEOINTIMA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 84907963747     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.08.014     Document Type: Article

References (33)

1. Alexander M.R., Owens G.K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 2012, 74:13-40.
2. Hao H., Gabbiani G., Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1510-1520.
3. Ferreira L.S., Gerecht S., Shieh H.F., Watson N., Rupnick M.A., Dallabrida S.M., Vunjak-Novakovic G., Langer R. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ. Res. 2007, 101:286-294.
4. Chen J., Kitchen C.M., Streb J.W., Miano J.M. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 2002, 34:1345-1356.
5. Creemers E.E., Sutherland L.B., McAnally J., Richardson J.A., Olson E.N. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 2006, 133:4245-4256.
6. Hayashi K., Saga H., Chimori Y., Kimura K., Yamanaka Y., Sobue K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J. Biol. Chem. 1998, 273:28860-28867.
7. Chamley-Campbell J., Campbell G.R., Ross R. The smooth muscle cell in culture. Physiol. Rev. 1979, 59:1-61.
8. Hultgardh-Nilsson A., Durbeej M. Role of the extracellular matrix and its receptors in smooth muscle cell function: implications in vascular development and disease. Curr. Opin. Lipidol. 2007, 18:540-545.
9. Hedin U., Thyberg J. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 1987, 33:239-246. (research in biological diversity).
10. Hedin U., Bottger B.A., Forsberg E., Johansson S., Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J. Cell Biol. 1988, 107:307-319.
11. Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 2007, 19:495-507.
12. Hannigan G.E., McDonald P.C., Walsh M.P., Dedhar S. Integrin-linked kinase: not so 'pseudo' after all. Oncogene 2011, 30:4375-4385.
13. Lynch D.K., Ellis C.A., Edwards P.A., Hiles I.D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 1999, 18:8024-8032.
14. Wu C., Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 2001, 155:505-510.
15. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
16. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731. (New York, N.Y.).
17. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 2001, 276:38349-38352.
18. Easton R.M., Cho H., Roovers K., Shineman D.W., Mizrahi M., Forman M.S., Lee V.M., Szabolcs M., de Jong R., Oltersdorf T., Ludwig T., Efstratiadis A., Birnbaum M.J. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 2005, 25:1869-1878.
19. Kawai-Kowase K., Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2007, 292:C59-C69.
20. Campbell G.R., Chamley-Campbell J.H. Invited review: the cellular pathobiology of atherosclerosis. Pathology 1981, 13:423-440.
21. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995, 75:487-517.
22. Wondimu Z., Gorfu G., Kawataki T., Smirnov S., Yurchenco P., Tryggvason K., Patarroyo M. Characterization of commercial laminin preparations from human placenta in comparison to recombinant laminins 2 (alpha2beta1gamma1), 8 (alpha4beta1gamma1), 10 (alpha5beta1gamma1). Matrix Biol. 2006, 25:89-93.
23. Rauch U., Saxena A., Lorkowski S., Rauterberg J., Bjorkbacka H., Durbeej M., Hultgardh-Nilsson A. Laminin isoforms in atherosclerotic arteries from mice and man. Histol. Histopathol. 2011, 26:711-724.
24. de Melker A.A., Sterk L.M., Delwel G.O., Fles D.L., Daams H., Weening J.J., Sonnenberg A. The A and B variants of the alpha 3 integrin subunit: tissue distribution and functional characterization. Lab. Investig. 1997, 76:547-563.
25. Kikkawa Y., Sanzen N., Fujiwara H., Sonnenberg A., Sekiguchi K. Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. J. Cell Sci. 2000, 113(Pt 5):869-876.
26. Ho B., Bendeck M.P. Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells. Cell Adhes. Migr. 2009, 3:174-176.
27. Shen D., Li J., Lepore J.J., Anderson T.J., Sinha S., Lin A.Y., Cheng L., Cohen E.D., Roberts J.D., Dedhar S., Parmacek M.S., Gerszten R.E. Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cells. Circ. Res. 2011, 109:616-628.
28. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J. Cell Biol. 1999, 145:727-740.
29. Bae S.S., Cho H., Mu J., Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 2003, 278:49530-49536.
30. Liu Z.P., Wang Z., Yanagisawa H., Olson E.N. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 2005, 9:261-270.
31. Fernandez-Hernando C., Ackah E., Yu J., Suarez Y., Murata T., Iwakiri Y., Prendergast J., Miao R.Q., Birnbaum M.J., Sessa W.C. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 2007, 6:446-457.
32. Fernandez-Hernando C., Jozsef L., Jenkins D., Di Lorenzo A., Sessa W.C. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2033-2040.
33. Dwivedi A., Sala-Newby G.B., George S.J. Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res. Cardiol. 2008, 103:244-256.